rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael L. Rankowitz

Director

Company insider

Files Form 4 as: Director, Veru; Director, Discover Financial Services.

In numbers

Trades disclosed
21
Buys
2
Sells
0
Bought
$84K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
2 Jul 2007
Last trade
4 May 2026
Last filed
6 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
VERU VeruDirector · Biotechnology · last 4 May 20262 buys · 0 sells
Discover Financial ServicesDirector · last 10 Apr 20080 buys · 0 sells

Activity over time

1 Feb 2025 – 1 Oct 2026
02Feb 25Jul 25Dec 25May 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 May 2026filed 6 May 2026VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
4 May 2026filed 6 May 2026VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
5 Dec 2025filed 9 Dec 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—3,000 at $0.00filing
1 Oct 2025filed 3 Oct 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—7,000 at $0.00filing
6 May 2025filed 8 May 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
19 Feb 2025filed 20 Feb 2025VERU VeruBiotechnologySEC FORM 4 Bought$32K54,721 at $0.58filing
18 Feb 2025filed 20 Feb 2025VERU VeruBiotechnologySEC FORM 4 Bought$52K95,279 at $0.55filing
1 Oct 2024filed 2 Oct 2024VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—85,000 at $0.00filing
6 Aug 2024filed 7 Aug 2024VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
2 Oct 2023filed 17 Nov 2023VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—90,000 at $0.00filing
9 May 2023filed 11 May 2023VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
2 Nov 2022filed 4 Nov 2022VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—95,000 at $0.00filing
3 Nov 2021filed 5 Nov 2021VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
13 Nov 2020filed 17 Nov 2020VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
14 Nov 2019filed 18 Nov 2019VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
13 May 2019filed 21 May 2019VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
17 Aug 2018filed 10 Sep 2018VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
20 Mar 2018filed 22 Mar 2018VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
10 Apr 2008filed 14 Apr 2008Discover Financial ServicesSEC FORM 4 Code A—7,022 at $0.00filing
15 Nov 2007filed 16 Nov 2007Discover Financial ServicesSEC FORM 4 Code A—164 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

K. Gary BarnetteChief Scientific Officer · Chief Scientific Officer at Veru, filing Form 4 there in the last year
Lucy LuDirector · Director at Veru, filing Form 4 there in the last year
Mitchell Shuster SteinerPresident and CEO · President and CEO at Veru, filing Form 4 there in the last year
Harry FischChief Corporate Officer · Chief Corporate Officer at Veru, filing Form 4 there in the last year
Grace HyunDirector · Director at Veru, filing Form 4 there in the last year